Top 50 Medical Device VC (Venture Capital) Funds in China in May 2026
Top 50 Medical Device VC (Venture Capital) Funds in China in May 2026
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- iMile — iMile is a logistics and courier services provider across the Middle East. It is the first courier company providing smart logistics and courier services to the e-Commerce business and brings the unique value of solving Cash On Delivery (COD). iMile offers a wide range of services like Cash on Delivery with tracking, Real-Time online tracking, 24hours Customer support through Email, Chat, Social Media, SMS, International Transport, Overseas warehouses, and last-mile delivery.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
- Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Seed
- China, Hong Kong, United States
Portfolio highlights
- Hengpujiguang — Hengpujiguang is a developer of 3D printing metal machine.
- Yinli Electric — Ningxia Yinli Electric Co., Ltd. is mainly engaged in the production and research and development of reactors and transformers. At present, the company's main products include: three-phase filter reactors, four-phase five-column reactors, water-cooled reactors, three-phase AC reactors, hollow core Reactors, isolation transformers andhigh-frequency transformers, etc.
- Depei Open Source — Depei Open Source is an AI and Robotics open source community in China.
We help founders build enduring companies.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Hong Kong
Portfolio highlights
- AnyiPu — AnyiPu is a leading high-tech enterprise in China dedicated to the research, development, production, sales, and full-cycle service of advanced chemical analysis and medical testing instruments. With a strong focus on innovation and quality, the company provides comprehensive solutions that support scientific research, industrial applications,clinical diagnostics, and public health.
- MindOn — MindOn is a robotics company that develops artificial intelligence software and algorithms to create humanoid robots.
- Ubiquitin Bio — Ubiquitin Bio is a research and development manufacturer of in vitro diagnostic products.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.
- LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
BIOCHING CAPITAL is an investment management firm.
Show more...Investment focus
- Medical Device, Medical, Biotechnology
- Angel, Series A, Seed
- China
Portfolio highlights
- Lunke Medical — Lunke Medical focuses on the research, development, production, and sales of medical devices, with particular strength and expertise in high-pressure technologies. The company is committed to delivering safe, reliable, and innovative solutions by combining advanced engineering, strict quality control, and continuous technological advancement tomeet the evolving needs of the medical industry.
- Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
- Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more...Investment focus
- Manufacturing, Software, Internet
- Series A, Series B, Series C
- China, India, United States
Portfolio highlights
- CertiK — CertiK, the largest Web3 security service provider, uses AI and formal verification to protect and monitor smart contracts and protocols, securing the Web3 ecosystem.
- Snapmaker — Snapmaker is dedicated to providing an integrated platform empowering everyone to create things with ease that just wasn’t there before.
- Shouxing Technology — AheadForm is pioneering the development of realistic humanoid robots designed to revolutionize human-robot interaction. Our current focus is on creating sophisticated humanoid robot heads that can express emotions, perceive their environment, and interact seamlessly with humans. By combining cutting-edge AI and advanced robotics, we aim to bring life to machines and transform the way humans engage with technology.
BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Singapore
Portfolio highlights
- Oukejian — Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.
- Aureka Biotechnologies — Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Angel, Series B
- China
Portfolio highlights
- XPTC — XPTC is a wafer slicing equipment developer, dedicated to the research, development, production, and sales of ultra-precision thinning cutting equipment and related consumables.
- Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
- Jianxin Jiaren — Jianxin Jiaren is a manufacturing business that creates and markets chemical products and raw materials. It uses a chemical recycling system, discarded waste textiles, and uses chemical decomposition technology to reduce waste polyester materials into small chemical molecules. It reduces dependence on petroleum resources and waste generation.
IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.
Show more...Investment focus
- Software, Internet, E-Commerce
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Jumeng — Jumeng is a developer of a logistic service platform. The company based in Shanghai, China.
- CreditEase — CreditEase is a business consulting firm that offers wealth management services. It caters areas such as wealth management, credit management, microfinance investment, and microcredit loan origination, and servicing. It operates a peer-to-peer platform that connects lenders with creditworthy borrowers, enabling under-banked students, professionals,and farmers to get loans. The company was founded in 2006 and is based in Beijing, China.CreditEase is a leading FinTech conglomerate in China, specializing in inclusive finance and wealth management, including payment technology, marketplace lending, crowdfunding, robo-advisory, insurance technology, and blockchain products and services. CreditEase actively engages with global FinTech innovators through business incubation, commercial cooperation and investment.
- Cloud Map and Action — CloudMap is an AI technology innovation company dedicated to exploring and breaking through cutting-edge technologies in geographic information and spatial intelligent computing.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more...Investment focus
- Manufacturing, Semiconductor, Electronics
- Series A, Series B, Funding Round
- China, Hong Kong, Singapore
Portfolio highlights
- Letuo Technology — Letuo Technology is a ASIC chip design & manufacturing firm focused on architecture and back end design, RTL coding, DFT, and synthesis.
- Heguang New Energy — Heguang New Energy is China's largest producer of square silicon cores for polysilicon and has long-term and stable purchase agreements with a number of major polysilicon producers.
- Matrix Software — Matrix Software is a research organization that focuses on the analysis, management, and prevention of information technology risks.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Series B
- China, India, Canada
Portfolio highlights
- PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
- BRC Biotechnology — BRC Biotechnology specializes in quality testing services for biopharmaceutical compliance. BRC Biotechnology supports biological agents, quality evaluation of biopharmaceutical goods such as cell gene therapy, nucleic acid medications, and vaccines.
- Fuzhi Internet Technology — Fuzhi Internet is a technology company focused on intelligent manufacturing in the apparel industry. It enhances collaboration across the apparel supply chain through digital solutions for production, management, and supply chain processes. Using a cloud-based platform, Fuzhi Internet enables traditional apparel companies to achieve intelligenttransformation, optimize production, and reduce costs.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
- Bloks Technology Group — Bruco uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bruco strives to create a whole ecological industry chain with "building blocks +"as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.
- Noitom Robotics — Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots, as well as the sale of consumer robots and the research and development of intelligent robots.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- BV Laser — BV Laser is a manufacturer of medical beauty equipment.
- Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- iOranges Automation — ioranges Automation is an AI & Robotics Company.
- Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
- Aureka Biotechnologies — Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Taiyu Investment is an investment firm.
Show more...Investment focus
- Medical, Medical Device, Biotechnology
- Series A, Angel, Seed
- China
Portfolio highlights
- NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
- Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series C, Series B
- China, United States, India
Portfolio highlights
- QureBio — QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug developmentincluding phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform.The company was founded in 2017 and is based in Pudong District, Shanghai.
- Pleryon Therapeutics — Innovations in biofunctional polymers
- Tingsheng Technology — TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digitalheart model.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- HjMicro — Hongjun Microelectronics is committed to the development of "higher efficiency and easier deployment" server processor (CPU) chips based on the ARM architecture, mainly for the data center cloud computing market.
- ZSPepLib — Zonsen PepLib Biotech Inc. Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA.
- Corerain Technologies — Corerain Technologies provides high performance AI acceleration solutions to embedding frontend, edge and backend AI devices.
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Hong Kong
Portfolio highlights
- Dongda Wanshen — Dongda Wanshen specialises in the selling and service of intelligent disinfection technology for hospitals and public health facilities.
- Huamei Haolian — Huamei Haolian specializes in providing telemedicine and medical tourism services.
- Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
SND Ventures Group is a venture capital and private equity firm specializing in seed investments.
Show more...Investment focus
- Manufacturing, Semiconductor, Health Care
- Series B, Series A, Seed
- China
Portfolio highlights
- Dezhi Matrix — Dezhi Matrix is focused on the larger semiconductor area, dedicated to constructing multimodal large-scale AI industrial models and delivering an AI-powered quality inspection solution.
- Tianmu Xinwang — Tianmu Xinwang is an AI perception technology company. It specializes in the research, development, manufacture, and distribution of automotive-grade, pure solid-state short-range LiDAR.
- Gongji Technology — Gongji is a technology-based company specializing in multi-source information fusion and positioning for intelligent vehicles.
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- AOSSCI — AOSSCI is an smart unmanned aircraft system developer Based in China.
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.
Goldport Capital is a Shenzhen-based asset management company.
Show more...Investment focus
- Manufacturing, Medical, Semiconductor
- Series A, Seed, Angel
- China
Portfolio highlights
- Yurucheng — Yurucheng is a brand of oral materials, specializing in the R&D, production, sales and service of medical oral materials and oral equipment.
- Zinc Core Titanium — Zinc Core Titanium makes special materials that light up and tiny screens for displays.
- Rongxin New Materials — Rongxin New Materials is a developer specializing in graphene material science and technology, with a commitment to the research and development of new materials technology and engineering applications. The company focuses on graphene-based heating films and graphene-integrated thermal products that are designed to provide efficient and uniformheating solutions for both consumer and industrial sectors.
SZHTI Group is a company that provides asset management and financing services.
Show more...Investment focus
- Manufacturing, Electronics, Semiconductor
- Series A, Angel, Funding Round
- China, United States
Portfolio highlights
- Pengxing Zhilian — Pengxing Zhilian firm specializes in the research and development of integrated electronic platforms for commercial aircraft and high-performance spaceborne computer payloads.
- Zhiqin Instruments — Zhiqin Instruments is an instrument supplier that offers full solutions for analysis and testing to important industries based on its own rapid detection mass spectrometer.
- Hongde New Materials — Hongde New Materials produces thermoplastic composite materials with fiber reinforcement. It offers energy storage and auxiliary components for solar and automobile power and steering systems.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- China, United States, Hong Kong
Portfolio highlights
- Vivatides Therapeutics — Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
- Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more...Investment focus
- Manufacturing, Information Technology, Software
- Series A, Series B, Seed
- China, Japan, United States
Portfolio highlights
- Raysun Technology — Raysun Technology is a enterprise specializing in the development, and manufacturing of laser equipment for the semiconductor industry.
- Spirit AI — Spirit AI develops 'Universal Brains' for robotics, specializing in general-purpose embodied models that bridge the gap between simulation and real-world deployment. These models provide robots with robust generalization and precise physical interaction capabilities across diverse environments. Technical efficacy is validated by theSpirit Series (notably Spirit v1.5), which currently leads the RoboChallenge global benchmarks. Through rigorous R&D, Spirit AI aims to integrate versatile robotic companions into the modern workforce, advancing the era of embodied AI.
- Hongde New Materials — Hongde New Materials produces thermoplastic composite materials with fiber reinforcement. It offers energy storage and auxiliary components for solar and automobile power and steering systems.
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more...Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Seed
- China
Portfolio highlights
- Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
- Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
- Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Nottada — Nottada is a manufacturer that focuses on the research and development of high-performance fibers and composite materials.
- Sanegene Bio — Sanegene Bio is currently operating in stealth mode.
- Mingche Technology — Mingche Technology is an innovative ophthalmic medical device company.
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
- Vivatides Therapeutics — Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
- Novachip Microelectronics — Novachip Microelectronics is a high-tech enterprise specializing in the design, research and development, and sales of advanced optoelectronic interconnect chips. The company is committed to providing cutting-edge chip products and comprehensive solutions that enable high-speed scale-up and scale-out interconnects in modern data centers.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more...Investment focus
- Artificial Intelligence, Medical, Biotechnology
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
- Mask Network — Your Portal To The New, Open Internet.
- Oricell Therapeutics — OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.
Insight Capital is a venture capital firm focused on early-stage investment.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Series C
- China
Portfolio highlights
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
- Iongen Therepeutics — Discovery of Novel Analgesics IonGen is a biotech company dedicated to the discovery of next-generation pain therapies without the addiction liabilities and side-effects associated with opioids.
ASBV focuses on early and mid-term venture capital investments.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Germany
Portfolio highlights
- Inspire-Robots — Inspire-Robots provides robot core components as well as intelligent operation solutions. They specialize in the research and development, production, and sales of micro linear actuators and EOAT, which include robotics, biomedical automation, industrial automation, education, scientific research, and other fields.
- Synaptic Medical — Synaptic Medical is a medical device company focused on the treatment of cardiac arrhythmias and other cardiovascular diseases.
- MicuRx Pharmaceuticals — MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available inChina. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Angel
- China
Portfolio highlights
- Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
- Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
- Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
Taiyu Investment is an investment firm.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Series A, Seed, Angel
- China
Portfolio highlights
- Immorna — Immorna specializes in the production of RNA-based therapeutics.
- ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
- Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more...Investment focus
- Health Care, Artificial Intelligence, Biotechnology
- Series A, Series B, Funding Round
- China, United States, Hong Kong
Portfolio highlights
- Alluxio — Accelerate AI workloads, increase GPU utilization, and reduce infrastructure costs with Alluxio's AI-optimized, highly-distributed cache.
- Triastek — Triastek develops 3D printed medicines and the production facilities to manufacture them and has already filed patent applications for its technology.
- Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Kang Ruijian — Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
- Onico Medical — Onico Medical is a medical device developer. The core team comes from the serious medical field and has absorbed professionals with rich experience in medical aesthetics development.
- Linyan Medical — Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.
Lightspeed China Partners was founded in 2011 as an independent venture capital group and began operating as Luminous Ventures in November 2025. Luminous Ventures is a leading venture capital firm serving entrepreneurs as a lead investor in early stage and emerging growth companies. It has offices in Shanghai,Beijing and Hong Kong.
Show more...Investment focus
- Manufacturing, Internet, Software
- Series A, Series B, Seed
- China, United States, Singapore
Portfolio highlights
- Laiye — Laiye's innovative Work Execution System(WES) and best-in-class Intelligent Automation (IA) platform, solutions, and products are making your businesses and workforce future-ready.
- Ballet — Ballet Crypto is a companion mobile app, which enables sending of cryptocurrency, checking market value and activating additional currencies. The use of the mobile app is completely optional, as you do not need it to receive and store your cryptocurrency safely.
- Yunmanman — Yunmanman is the first full mobile Internet-based technologies and development of all applications free mobile APP is committed to providing efficient tube car picking tool for road transport and logistics industry, but for the car to find goods (picking), find goods vehicles ( shipping) provides comprehensive information and transaction services.Yun full membership subtle Shanghai Information Consulting Co., the company is headquartered in Shanghai's Jiading Industrial Zone, green neighborhood, co-founded by a number of executives and many Alibaba logistics industry experts.
Qingrong Ventures is an Investment firm.
Show more...Investment focus
- Medical, Medical Device, Health Care
- Seed, Angel
- China
Portfolio highlights
- BrainThink — BrainThink integrates wearable sensors to deliver scalp electroencephalogram (EEG) and heart rate variability (HRV). BrainThink provides fast assessment for depression, anxiety, motor imagery, and attention.
- Yuansheng Intelligence — Yuansheng Intelligence is a manufacturer of intricate rehabilitation and nursing medical hardware.
Wuxi Capital is a financial investment platform.
Show more...Investment focus
- Manufacturing, Health Care, Medical
- Seed, Series B, Series A
- China, United States, Germany
Portfolio highlights
- Zelos — Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models.
- Gaze Technology — Gaze Technology is an innovative company specializing in the development of near-space aerostats—high-altitude, lighter-than-air platforms designed for operations in the stratosphere.
- Zhongdi Semiconductor — Zhongdi Semiconductor specializes in indium phosphide (InP) single crystals essential for optical communication and integrated circuits.
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, Singapore, United States
Portfolio highlights
- Weimai — Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing userswith a family doctor application in every home.
- Haofeng Medtech — Haofeng Medtech is a CDMO service provider of interventional medical devices.
- Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing,Shanghai and Hefei.
Show more...Investment focus
- Manufacturing, Semiconductor, Health Care
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- PaXini Tech — All Scenario Application—Haptic Digitization and Tactile Technology
- Ganwei Technology — Wuhan Ganwei Technology is a manufacturer of gas instruments and meters. Its main products include short optical path gas pools, online ultraviolet gas analyzers, gas sensors, oil and gas infrared spectroscopy logging tools, and high-precision automatic gas distribution instruments, etc., which are mainly used in environmental protection,Petrochemical and other fields.
- Changzhou Fuxing Mechanical and Electrical Co. — Changzhou Fuxing Mechanical and Electrical Co. manufactures servo, brushless DC, and hybrid stepper motors.
Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.
Show more...Investment focus
- Software, Artificial Intelligence, E-Commerce
- Series A, Series B, Series C
- China, United States, Singapore
Portfolio highlights
- YQN — YQNLink specializes in digital logistics, providing a comprehensive suite of international logistics services. This includes sea freight, air freight, rail freight, and multimodal transportation solutions. With a focus on leveraging digital technology, YQNLink aims to enhance supply chain transparency and efficiency, making shipping processessimpler for businesses. The company offers consultative services to tailor logistics solutions to specific business needs, ensuring a streamlined and effective logistics strategy. YQNLink's acquisition of COPE, a cross-border e-commerce logistics firm, further expands its capabilities in serving the e-commerce sector.
- SeeYA Technology — SeeYA Technology is a high-tech company specializing in R&D, design, production and sales of new-generation semiconductor OLEDoS display, and providing customers with micro-display components, modules and related solutions. There is a comprehensive product line to full fill different demands from AR/VR, drones, thermal devices, nightvision equipment etc.
- Starna Therapeutics — Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, South Korea
Portfolio highlights
- iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
- Wala English — Wala English is a provider of comprehensive full-process AI contextual learning services, leveraging artificial intelligence to deliver personalized, immersive language learning experiences that adapt to each learner’s needs, context, and progress throughout their educational journey.
- Hertz Life Science Technology — Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes theresearch and development of vaccines.At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen's Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises.
CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporationprovides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.
Show more...Investment focus
- Biotechnology, Health Care, Manufacturing
- Series B, Series A, Series C
- China, United States, Japan
Portfolio highlights
- Xiaoyu Zhizao — Xiaoyu Zhizao is an industrial robot manufacturer, focusing on industrial robot manufacturing, intelligent robot research and development.
- SeeYA Technology — SeeYA Technology is a high-tech company specializing in R&D, design, production and sales of new-generation semiconductor OLEDoS display, and providing customers with micro-display components, modules and related solutions. There is a comprehensive product line to full fill different demands from AR/VR, drones, thermal devices, nightvision equipment etc.
- Deep Robotics — Deep Robotics specializes in the application of the global quadruped robot industry. The founding team is rooted in Zhejiang University and has more than ten years of robotics research and development background. It is a high-tech company that attaches great importance to research and development and takes core technology as its maincompetitiveness. Sunshine has mastered the key core technology of quadruped robot motion control and has a number of independent and controllable intellectual property rights. The self-developed "Jueying" series of robots have reached the advanced level among similar products in the world and has been the first to be put into use in electric power, tunnel, fire protection, security, and other fields. Since its establishment in 2017, Yunshen has completed the R&D and sales layout of four series of products conducted multiple rounds of financing and built a complete organizational system. With the increasingly mature application of the quadruped robot industry, the company has entered a channel of rapid development.
Founded in June 2012 by Liu Xiaosong, Dong Zhanbin, and Su Wei, three Internet and investment circle veterans, Qingsong Fund is an early venture capital firm specializing in investment in education, social networking, consumerism, innovation, technology and applications. It manages four RMB funds with a total value of about RMB 2 billion. So far,it has invested in more than 140 companies, including 1 to 1 head, 1 DaDa English, squirrel AI, onion mathematics, wedding calendar, werewolf killing, flystep technology, HomeFacial. Pro and other star projects - 50% exit project returns more than 60 times, multiple project valuation multiples increased nearly 200 times, and educational projects have an average annual value increase of 500%. Among them, the Qingsong Smart Fund, which was newly established in 2018, focuses on the underlying technologies of the underlying AI and Smart Connect, as well as investment in such areas as smart healthcare, enterprise services and intelligent transportation applications. Liu Xiaosong, founding partner of Qingsong Fund, is a Ph.D. student at Tsinghua University. He invested in Tencent in 1999 and has a return on investment of tens of thousands of times. In 2000, he founded A8 New Media Group, which was successfully listed on the main board in Hong Kong in 2008. In 2015, he hatched in November 2018. Listed in Hong Kong stocks in the year. As a leading early investment institution in China, Qingsong Fund and its founding partners have repeatedly won Top 10 of Zero2IPO China's early investment institutions/investors, Top10 of China's education sector, Top100 of Chinese investors, and China's best early venture capital investment. Institution/Investor Top10; 36氪 China's new entertainment sector investment institutions Top10, online education sector investment institutions/investors Top10 and other mainstream awards.
Show more...Investment focus
- Manufacturing, Internet, Education
- Series A, Angel, Seed
- China, United States, Canada
Portfolio highlights
- Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
- Shufang New Energy — Shenzhen Sufang New Energy focuses on the research, development, and production of lithium-rich manganese-based cathode materials.
- Tongwei New Energy — Tongwei New Energy is a company that manufactures zero-carbon solid oxide fuel cells. Its major product is distributed zero-carbon power plants.
CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.
Show more...Investment focus
- Health Care, Biotechnology, Manufacturing
- Series A, Series B, Series C
- China, United States
Portfolio highlights
- Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
- Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.
- Huamei Titanium Technology — Huamei Titanium Technology specializes in the research, development, and manufacturing of liquid crystal phased array antennas.
Yuanhui Chuangyi is an investment firm.
Show more...Investment focus
- Medical Device, Beauty, Industrial
- Seed, Series A
- China
Portfolio highlights
- Toll PATEO — Toll PATEO is a natural science, medical research and experimental development service provider.
- Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
- Xijian Technology — Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology. It focuses on health disciplines such as sports rehabilitation, dermatology and beauty, and disease diagnosis and treatment.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!